PhD (2013) in Pharmacy (Pharmaceutical Technology), Universidade de Lisboa
Quality Control Manger and Head of Research Department at Laboratório Edol, Produtos Farmacêuticos SA
Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
Sara Raposo is a team member of the Nano2B research group. Her research is focused on the development of new drug carriers for topical drug delivery, including cutaneous and ophthalmic administration. This research involves a multidisciplinary platform and, it is mainly based on Pharmaceutical Technology.
Ascenso A, Raposo S, Batista C, Cardoso C, Mendes T, Praça G, Bentley M, Simões S. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes. Int J Nanomedicine 2015; 18: 5837-5851.
Menezes AC, Raposo S, Simões S, Ribeiro H, Oliveira H, Ascenso A. Prevention of photocarcinogenesis by agonists of 5-HT1A and antagonists of 5-HT2A receptors. Mol Neurobiol 2015; 53: 1145-1164
Raposo S, Tavares R, Gonçalves L, Simões S, Urbano M, Ribeiro HM. Mometasone-furoate – loaded cold processed oil-in-water emulsions for epidermal targeting: in vitro and in vivo studies. Drug Delivery 2015; 22: 562-572.
Raposo S, Salgado A, Gonçalves L, Pinto CP, Urbano M, Ribeiro HM. Safety Assessment and Efficacy Aspects of a New Cold Processed Sil Emulsion as a vehicle for glucocorticoids. BioMed Research International; 2013; Article ID 181634, 10 pages.
Raposo S, Simões S, Almeida AJ, Ribeiro HM. Advanced systems for glucocorticoids dermal delivery. Expert Opin Drug Deliv 2013; 10: 855-77